Investment Considerations Progressive Care reported a 5% year-over-year revenue increase to approximately $40.6 million for the year ended December 31, 2022. The company’s prescription revenue increased 7% year-over-year to $36.3 million during that same period. In 2022, Progressive Care received nearly $6 million from a strategic investment transaction with NextPlat Corporation. The company launched its … Continue reading “Progressive Care Inc. (OTCQB: RXMD)”
Symbol | Release | Time |
---|---|---|
{{ release.qmtopics.qmsymbol[0].symbol }} | {{ release.headline }} | {{ release.datetime | amDateFormat:'hh:mm A'}} |